top of page
BPIQ Blog
Jun 24, 20223 min read
Biopharma Pulse - 6/20-6/24 Week in Review
As we reach the middle of June, we review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and...
Jun 24, 20222 min read
Biopharma Daily Stock Updates - 06/24/22
$XBI $77.06 | +1.09% Table of Contents: Pipeline Updates Business Updates Pipeline Updates #IKNA +29.4% (6/22) Ikena Oncology Receives...
Jun 24, 20222 min read
Free Biopharma Daily Stock Updates - 06/24/22
$XBI $77.06 | +1.09% Table of Contents: Pipeline Updates Business Updates Pipeline Updates #IKNA +29.4% (6/22) Ikena Oncology Receives...
Jun 23, 20222 min read
Biopharma Daily Stock Updates - 06/23/22
$XBI $76.23 | +6.18% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #NVAX +14% Novavax Files...
Jun 23, 20222 min read
Free Biopharma Daily Stock Updates - 06/23/22
$XBI $76.23 | +6.18% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #NVAX +14% Novavax Files...
Jun 21, 20223 min read
Biopharma Daily Stock Updates - 06/21/22
$XBI $70.03 | +3.58% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #OCGN +4.6% Ocugen Announces...
Jun 21, 20223 min read
Free Biopharma Daily Stock Updates - 06/21/22
$XBI $70.03 | +3.58% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #OCGN +4.6% Ocugen Announces...
Jun 17, 20222 min read
Biopharma Pulse - 6/13-6/17 Week in Review
As we reach the middle of June, we review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and...
Jun 13, 20223 min read
Biopharma Daily Stock Updates - 06/13/22
$XBI $63.32 | -5.53% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #NVAX -10.7% Novavax COVID-19...
Jun 13, 20223 min read
Free Biopharma Daily Stock Updates - 06/13/22
$XBI $63.32 | -5.53% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #NVAX -10.7% Novavax COVID-19...
Jump start your biotech due diligence
Our platform helps you uncover your next biotech investment opportunity
bottom of page